1 June 2012
Further evidence has been given that non-steroidal anti-inflammatory drugs (NSAIDs) can help in the battle against various forms of cancer.
Earlier this week, Sigrun Alba Johannesdottir, of the Aarhus University Hospital in Denmark, led a team of researchers in a study which found that the medication can significantly reduce the effects of skin cancer from developing.
Now, scientists from the Universities of Bristol and Sheffield have claimed that NSAIDs can have more widespread benefits.
The researchers studied translucent zebrafish larvae as part of their investigation, in which they found that drugs like aspirin can starve cancer cells of white blood cells that act as the disease's early-growth support.
Paul Martin, professor of Cell Biology at the University of Bristol's Schools of Biochemistry and Physiology and Pharmacology, noted: "These findings are important as they help explain the underlying cellular processes at work which could be used to develop potential new therapies for eliminating early-stage cancer in humans."
Posted by Jeanette Royston
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.